Vivesto
0.262 SEK -2.78%2 investors are following this company
Vivesto is a research company. The company specializes in the research and development of drugs for serious diseases in oncology. The technology is based on the company's technical platform where research is based on nanotechnology. Today, operations are conducted mainly in the Nordic countries and North America. The company was founded in 1999 and has its headquarters in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
VIVE
Daily low / high price
0.258 / 0.27
SEK
Market cap
140.97M SEK
Turnover
277.41K SEK
Volume
1.1M
Latest videos
Financial calendar
Interim report
2024-08-22
Interim report
2024-11-21
Annual report
2025-02-20
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Per Arwidsson med bolag | 24.8 % | 24.8 % |
Avanza Pension | 5.8 % | 5.8 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Vivesto receives positive Cantrixil preclinical efficacy data
Vivesto får positiva prekliniska effektdata för Cantrixil
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools